These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31503152)

  • 21. Prevalence of early discontinuation and associated factors among a retrospective cohort of etonogestrel contraceptive implant users.
    Peterson AM; Brown A; Savage A; Dempsey A
    Eur J Contracept Reprod Health Care; 2019 Dec; 24(6):475-479. PubMed ID: 31545110
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of Topiramate on Serum Etonogestrel Concentrations Among Contraceptive Implant Users.
    Lazorwitz A; Pena M; Sheeder J; Teal S
    Obstet Gynecol; 2022 Apr; 139(4):579-587. PubMed ID: 35594123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etonogestrel contraceptive implant uptake and safety among solid organ transplant recipients.
    Lew J; Sheeder J; Lazorwitz A
    Contraception; 2021 Nov; 104(5):556-560. PubMed ID: 34147509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Menstrual bleeding patterns in adolescents using etonogestrel (ENG) implant.
    Deokar AM; Jackson W; Omar HA
    Int J Adolesc Med Health; 2011; 23(1):75-7. PubMed ID: 21721368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Twelve-month Continuation of the Etonogestrel Implant in Adolescents With Polycystic Ovary Syndrome.
    Buyers E; Sass AE; Severn CD; Pyle L; Cree-Green M
    J Pediatr Adolesc Gynecol; 2021 Feb; 34(1):33-39. PubMed ID: 32919086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness and continuation rates of the etonogestrel-subdermal contraceptive implant versus short-acting contraceptive methods offered at no cost in Campinas, Brazil.
    Laporte M; Marcelino AC; da Cunha Pereira P; Espejo-Arce X; Juliato CT; Bahamondes L
    Int J Gynaecol Obstet; 2024 Jul; 166(1):305-311. PubMed ID: 38328989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
    Akerlund M; Røde A; Westergaard J
    Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaginal bleeding patterns of women using different contraceptive methods (implants, injectables, IUDs, oral pills)--an Indian experience. An ICMR Task Force Study. Indian Council of Medical Research.
    Datey S; Gaur LN; Saxena BN
    Contraception; 1995 Mar; 51(3):155-65. PubMed ID: 7621684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective pilot study to assess the impact of the etonogestrel implant on postpartum depression.
    Ross CM; Hammond C; Ralph JA; Balmert LC; Wisner KL; Kiley JW
    Eur J Contracept Reprod Health Care; 2021 Apr; 26(2):98-104. PubMed ID: 33164593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of the etonogestrel implant and levonorgestrel intrauterine device beyond the U.S. Food and Drug Administration-approved duration.
    McNicholas C; Maddipati R; Zhao Q; Swor E; Peipert JF
    Obstet Gynecol; 2015 Mar; 125(3):599-604. PubMed ID: 25730221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Etonogestrel concentrations among contraceptive implant users in Botswana using and not using dolutegravir-based antiretroviral therapy.
    Bishop IJ; Gertz AM; Simon B; Tawe L; Lechiile K; Liu S; Teodoro N; Mussa A; Avalos A; Malima S; Maotwe T; Mokganya L; Westhoff CL; Morroni C
    Contraception; 2020 Sep; 102(3):174-179. PubMed ID: 32387328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and factors associated with early discontinuation rate of Implanon utilization among women who ever used Implanon in Kucha District Gamo Gofa Zone, Southern Ethiopia.
    Mamecha Mesha ; Akalewold Alemayehu ; Deresse Daka
    BMC Womens Health; 2020 Oct; 20(1):239. PubMed ID: 33097056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Migration of etonogestrel subcutaneous contraceptive implants: systematic review and recommendations for practice.
    Guilbert É; Arguin H; Bélanger M
    Eur J Contracept Reprod Health Care; 2024 Jun; 29(3):115-130. PubMed ID: 38712717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of etonogestrel subcutaneous implant in Sardinia, Italy: women's compliance and satisfaction.
    Capobianco G; Sanna E; Gulotta A; Virdis G; Dessole F; Maida I; Madonia M; Cudoni F; Petrillo M
    Eur J Contracept Reprod Health Care; 2024 Aug; 29(4):171-176. PubMed ID: 38785129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insertion and 3-year follow-up experience of 372 etonogestrel subdermal contraceptive implants by family physicians in Granada, Spain.
    Arribas-Mir L; Rueda-Lozano D; Agrela-Cardona M; Cedeño-Benavides T; Olvera-Porcel C; Bueno-Cavanillas A
    Contraception; 2009 Nov; 80(5):457-62. PubMed ID: 19835720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pilot study on the effect of isotretinoin on serum etonogestrel concentrations in contraceptive implant users.
    Lazorwitz A; Seale R; Davis A; Guiahi M
    Contraception; 2020 Jul; 102(1):58-60. PubMed ID: 32325076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
    Modesto W; Bahamondes MV; Bahamondes L
    Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Menstrual bleeding patterns in Norplant-2 implant users.
    Biswas A; Leong WP; Ratnam SS; Viegas OA
    Contraception; 1996 Aug; 54(2):91-5. PubMed ID: 8842585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Immediate Postpartum Etonogestrel Implant Insertion and Venous Thromboembolism.
    Floyd JL; Beasley AD; Swaim LS; Turrentine MA; Nijjar JB
    Obstet Gynecol; 2020 Jun; 135(6):1275-1280. PubMed ID: 32459418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bleeding profile in users of an etonogestrel sub-dermal implant: effects of anthropometric variables. An observational uncontrolled preliminary study in Italian population.
    Di Carlo C; Guida M; De Rosa N; Sansone A; Gargano V; Cagnacci A; Nappi C
    Gynecol Endocrinol; 2015 Jun; 31(6):491-4. PubMed ID: 26213863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.